Future studies should explore the regulatory mechanisms of PM20D1 and its role in lipid metabolism in IPAH, as well as investigate the therapeutic potential of targeting PM20D1 in the treatment of IPAH. The gene discussed is PM20D1; the disease is idiopathic pulmonary arterial hypertension.